<VariationArchive VariationID="855264" VariationName="NM_000268.4(NF2):c.431dup (p.Tyr144Ter)" VariationType="Duplication" Accession="VCV000855264" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="849194" VariationID="855264">
      <GeneList>
        <Gene Symbol="NF2" FullName="NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor" GeneID="4771" HGNC_ID="HGNC:7773" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29603556" stop="29698600" display_start="29603556" display_stop="29698600" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29999544" stop="30094588" display_start="29999544" display_stop="30094588" Strand="+" />
          </Location>
          <OMIM>607379</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000268.4(NF2):c.431dup (p.Tyr144Ter)</Name>
      <CanonicalSPDI>NC_000022.11:29642268:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29642268" stop="29642269" display_start="29642268" display_stop="29642269" variantLength="1" positionVCF="29642268" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="30038257" stop="30038258" display_start="30038257" display_stop="30038258" variantLength="1" positionVCF="30038257" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y144*</ProteinChange>
      <ProteinChange>Y102*</ProteinChange>
      <ProteinChange>Y103*</ProteinChange>
      <ProteinChange>Y61*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.30038258dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.30038258dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.29642269dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.29642269dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009057.1" sequenceAccession="NG_009057" sequenceVersion="1" change="g.43714dup">
            <Expression>NG_009057.1:g.43714dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000268.4" sequenceAccession="NM_000268" sequenceVersion="4" change="c.431dup" MANESelect="true">
            <Expression>NM_000268.4:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000259.1" sequenceAccession="NP_000259" sequenceVersion="1" change="p.Tyr144Ter">
            <Expression>NP_000259.1:p.Tyr144Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016418.5" sequenceAccession="NM_016418" sequenceVersion="5" change="c.431dup">
            <Expression>NM_016418.5:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057502.2" sequenceAccession="NP_057502" sequenceVersion="2" change="p.Tyr144Ter">
            <Expression>NP_057502.2:p.Tyr144Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181825.3" sequenceAccession="NM_181825" sequenceVersion="3" change="c.431dup">
            <Expression>NM_181825.3:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861546.1" sequenceAccession="NP_861546" sequenceVersion="1" change="p.Tyr144Ter">
            <Expression>NP_861546.1:p.Tyr144Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181828.3" sequenceAccession="NM_181828" sequenceVersion="3" change="c.305dup">
            <Expression>NM_181828.3:c.305dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861966.1" sequenceAccession="NP_861966" sequenceVersion="1" change="p.Tyr102Ter">
            <Expression>NP_861966.1:p.Tyr102Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181829.3" sequenceAccession="NM_181829" sequenceVersion="3" change="c.308dup">
            <Expression>NM_181829.3:c.308dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861967.1" sequenceAccession="NP_861967" sequenceVersion="1" change="p.Tyr103Ter">
            <Expression>NP_861967.1:p.Tyr103Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181830.3" sequenceAccession="NM_181830" sequenceVersion="3" change="c.182dup">
            <Expression>NM_181830.3:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861968.1" sequenceAccession="NP_861968" sequenceVersion="1" change="p.Tyr61Ter">
            <Expression>NP_861968.1:p.Tyr61Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181831.3" sequenceAccession="NM_181831" sequenceVersion="3" change="c.182dup">
            <Expression>NM_181831.3:c.182dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861969.1" sequenceAccession="NP_861969" sequenceVersion="1" change="p.Tyr61Ter">
            <Expression>NP_861969.1:p.Tyr61Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181832.3" sequenceAccession="NM_181832" sequenceVersion="3" change="c.431dup">
            <Expression>NM_181832.3:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861970.1" sequenceAccession="NP_861970" sequenceVersion="1" change="p.Tyr144Ter">
            <Expression>NP_861970.1:p.Tyr144Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181833.3" sequenceAccession="NM_181833" sequenceVersion="3" change="c.431dup">
            <Expression>NM_181833.3:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861971.1" sequenceAccession="NP_861971" sequenceVersion="1" change="p.Tyr144Ter">
            <Expression>NP_861971.1:p.Tyr144Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_156186.2" sequenceAccession="NR_156186" sequenceVersion="2" change="n.913dup">
            <Expression>NR_156186.2:n.913dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_511" sequenceAccession="LRG_511">
            <Expression>LRG_511:g.43714dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t1" sequenceAccession="LRG_511t1">
            <Expression>LRG_511t1:c.431dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t2" sequenceAccession="LRG_511t2">
            <Expression>LRG_511t2:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_511p2" sequenceAccession="LRG_511p2" change="p.Tyr144Ter">
            <Expression>LRG_511p2:p.Tyr144Ter</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181832.2" sequenceAccession="NM_181832" sequenceVersion="2" change="c.431dupA">
            <Expression>NM_181832.2:c.431dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2065831369" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000268.4(NF2):c.431dup (p.Tyr144Ter) AND Neurofibromatosis, type 2" Accession="RCV001060499" Version="8">
        <ClassifiedConditionList TraitSetID="840">
          <ClassifiedCondition DB="MedGen" ID="C0027832">Neurofibromatosis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000268.4(NF2):c.431dup (p.Tyr144Ter) AND NF2-related disorder" Accession="RCV003413876" Version="4">
        <ClassifiedConditionList TraitSetID="89292">
          <ClassifiedCondition>NF2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-23" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16983642</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9643284</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="89292" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71281" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NF2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NF2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3089" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NF 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis central type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic schwannomas bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bilateral acoustic neurofibromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic neurinoma bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCHWANNOMATOSIS, VESTIBULAR</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurofibromatosis, type 2</ElementValue>
                <XRef ID="Neurofibromatosis+type+2/5175" DB="Genetic Alliance" />
                <XRef ID="92503002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BANF</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SWNV</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ACN</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000552306" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552305" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514608" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335548" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552308" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576339" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335543" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511190" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528652" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551653" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521547" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510681" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551659" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neurofibromatosis 2 (NF2) is characterized by bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction. The average age of onset is 18 to 24 years. Almost all affected individuals develop bilateral vestibular schwannomas by age 30 years. Affected individuals may also develop schwannomas of other cranial and peripheral nerves, meningiomas, ependymomas, and, very rarely, astrocytomas. Because NF2 is considered an adult-onset disease, it may be underrecognized in children, in whom skin tumors and ocular findings (retinal hamartoma, thickened optic nerves, cortical wedge cataracts, third cranial nerve palsy) may be the first manifestations. Mononeuropathy that occurs in childhood is an increasingly recognized finding; it frequently presents as a persistent facial palsy or hand/foot drop.</Attribute>
                <XRef ID="NBK1201" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7193" />
                <XRef ID="7193" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301380</ID>
                <ID Source="BookShelf">NBK1201</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2020">
                <ID Source="PubMed">32602153</ID>
              </Citation>
              <XRef ID="637" DB="Orphanet" />
              <XRef ID="C0027832" DB="MedGen" />
              <XRef ID="MONDO:0007039" DB="MONDO" />
              <XRef Type="MIM" ID="101000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2390692" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4963030|MedGen:C0027832" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001225192" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9643284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16983642</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr144*) in the NF2 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in NF2 are known to be pathogenic (PMID: 9643284, 16983642). This nonsense change has been observed in individuals affected with neurofibromatosis type 2 (PMID:¬†9817921,¬†15684865¬†, 18033041). This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.30038257_30038258insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027832" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7693797" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3590184|NF2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004118417" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NF2 c.431dupA variant is predicted to result in premature protein termination (p.Tyr144*). This variant was reported in an individual with neurofibromatosis type 2 (Patient 150 in Kluwe et al. 1998. PubMed ID: 9817921). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in NF2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_181832.2:c.431dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NF2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7693797" TraitType="Disease" MappingType="Name" MappingValue="NF2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NF2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2390692" TraitType="Disease" MappingType="XRef" MappingValue="C0027832" MappingRef="MedGen">
        <MedGen CUI="C0027832" Name="Neurofibromatosis, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

